Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix H. LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Shares Traded Last Trade
  +7.00p +7.95% 95.00p 275,267 15:26:57
Bid Price Offer Price High Price Low Price Open Price
93.00p 97.00p 97.00p 88.00p 88.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.19 1.69 2.43 39.1 80.1

Optibiotix H. (OPTI) Latest News

More Optibiotix H. News
Optibiotix H. Takeover Rumours

Optibiotix H. (OPTI) Share Charts

1 Year Optibiotix H. Chart

1 Year Optibiotix H. Chart

1 Month Optibiotix H. Chart

1 Month Optibiotix H. Chart

Intraday Optibiotix H. Chart

Intraday Optibiotix H. Chart

Optibiotix H. (OPTI) Discussions and Chat

Optibiotix H. Forums and Chat

Date Time Title Posts
22/9/201821:48OptiBiotix - Better Science, Better Health. Better buy some!41,609
14/9/201818:38OptiBiotix - The uncensored thread 2,593
16/8/201809:38more sugar vicar?3 Bags full Yes pls!gla27
01/8/201809:21Free Shares1

Add a New Thread

Optibiotix H. (OPTI) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Optibiotix H. trades in real-time

Optibiotix H. (OPTI) Top Chat Posts

Optibiotix H. Daily Update: Optibiotix H. is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix H. was 88p.
Optibiotix H. has a 4 week average price of 85p and a 12 week average price of 63p.
The 1 year high share price is 133p while the 1 year low share price is currently 54p.
There are currently 84,366,641 shares in issue and the average daily traded volume is 273,099 shares. The market capitalisation of Optibiotix H. is £80,148,308.95.
onceabroker1: BULLS versus BEARS I am balls deep in OPTI. i basically listen to both sides of the argument on OPTI - the negatives and the positives. Never discount anything. For my own benefit as much as anything else I list the bull versus the bear case. BULLS: i) The micro biome space is set for very high growth. OPTI is at the cutting edge and has a first mover advantage ii) OPTI has proven IP - this is backed up by the fact that as SOH says there has been interest in buying parts of the business iii) OPTI has a diversified business model - it is involved in cholesterol, weight management, sugars and has a 42% stake in skin. It does both B2C and B2B iv) It has a very lean cost base - they don't even have an office. Operating costs are c.£1.5m p/a. This means that any revenue drops to the bottom line v) It has signed c.20 commercial deals in the last 18m and is set to sign many more vi) The recent pharma deal validates the technology and provides a strong reference client to sign up more commercial food supplement deals. The fact that the unnamed pharma company is prepared to fund development of OPTI's strain through FDA trials to commercialisation is testament to the attractiveness of their technology vii) OPTI will start to generate meaningful revenues in Q418/2019. Its "Intel Inside" business model with milestones/licensing revenue/royalties is extremely astute viii) Putting the company on a multiple of 25x (fair for a high growth business) means you only need £3m of profit to justify the current market cap ix) Due to the low cost nature of the business, it is unlikely they will come to the market for more funds. There are only c.80m shares in circulation BEARS: i) OPTI's business is at best a fad at worst a scam. Probiotics don't work ii) OPTI doesn't have any defensible IP and anybody can come in and develop their own strains iii) How can you justify a £75m market cap with no revenues? The share price is a bubble iv) OPTI will have to come to market to raise more money v) Management are unimpressive and unproven. They seem intent on pumping up the share price Thats all I can think of at the moment but I'm sure there are other points for both the bull and the bear cases. Anyway, it seems to me that there are more bull points than bear points. I am a happy holder with a current in price of 93p
greenas1953: Enjoying the rise in the opti share price since I first invested here July 15. And imho there is plenty more to come. I am not surprised rayrac is hurting, his investments have been soul destroying, Monkeywench on the other hand I find truly pathetic a really silly poster doing playground stuff. Good luck all long term holders this is a good share to hold.
kmann: further proving what a pointless product this is. Like all slimming products, false hope for the hopeless. Instructions, eat or drink our product once a day, and you WILL lose weight. Because eating less of anything will cause you to lose weight. EVERY slimming product for years, selling the same message, and most proven to be worthless. Leading to disillusionment, a bit like the opti share price Just eat less, cut out the expensive middleman, and while your at it, do some exercise.
mshilos: In my view, this interview with Opti's CEO throws up a number of red flags whilst the company is valued at £55m but yet to produce any revenues:- hTTp:// 1) Note how often the CEO refers to the share price. CEO should be talking about revenues and profits not the share price. Needless to say, not once are revenues and potential profits mentioned. 2) He appears to think that because peer group companies are highly over-valued then OptiBiotix shares should be highly over-valued too. Ridiculous. It just means the whole sector may be due a nasty surprise. 3) The CEO mentions the whole market opportunity but never once tells investors what slice OptiBiotix are likely to achieve. 4) He keeps referring to growth, but what does he mean since no dates are given regarding revenues let alone profits. What company growth has been achieved then? Headcount and outgoings? 5) CEO says the following :- "The sugars will come much later that's really cutting edge science and that's where the biggest opportunity is". In other words, their biggest market is still light years away. Investors should expect plenty of dilutive placings in the next few years. 6) The first market that they are going to address is the over the counter supplements market. This is a market that is already massively over-crowded. Marketing spend would be huge just to make the slightest penetration. 7) He recognises that Asian markets are a problem. They will just pinch the IP without so much as a by-your-leave. I notice that investors were getting over-excited about a sugar tax today. LOL. See point (5). Revenues and profits are years away yet, and the company is valued at £55m. Who knows what will happen to the share price in the short term, but if I'd made a decent profit already I'd take it off the table because the slightest smell of missed deadlines, disappointments and/or delays with soon smash the share price. There is no margin of safety. Investors will need a constant flow of jam tomorrow RNS's and continued ramping to keep the share price moving forward. Otherwise...............
siennadelekat21: Dire,I'm afraid Monkey is a premium subscriber and as a result advfn will do nothing about him. Before OPTI, he infested the CPX board for ages until the share price actually did well. Hopefully when the OPTI share price moves up further he will eventually move on and infest another board (fingers crossed).Sienna
michaelmouse: 16 March 2016 (start of thread) - Opti share price was 74p. Today it's up 59%. That's about 22% compounded per annum. Pretty good but not spectacular yet!! I wouldn't touch either Opti or Sbtx with a barge pole, but good luck anyway. Overvalued shares getting even more overvalued and a great example of irrational exuberance by the numpties! Both have ridiculous multi-million market caps with next to zero revenues reported. In the end it's always the figures that dictate the share price. See CPT today. I'll watch and wait. Let me know if you take profits. It might be the sensible option at this stage before the bubble bursts. If I was SOH I'd cash in the sbtx shares (if he can sell all his 42%) before the bear market really revs up because (whilst it's difficult to detect) I think this is the start. ;)
parob: I personally don't think SBTX is priced in to the OPTI share price - LPL-DL, SlimBiome, LPGOS, and Sweetbiotix combined are easily worth £100M plus imo. In fact I would have thought announcing a divi of 12p would give the shares a boost! Let's see what comes of these multi-billion turnover company Sweetbiotix deals. If any "cross the product launch line" then a valuation of £100m NOW for Sweetbiotix isn't out of the question. Corporate's will pay huge premiums to block their competitors from market penetration.
michaelmouse: slarty - This isn't the trak thread, but trak's share price performance has been poor over those two years but terrific over a longer period, not dissimilar to Opti's share price performance (as already mentioned), although of course trak's share price reached far greater heights at one stage. However, (currently) trakm8 is at worst fairly priced (and possibly hugely undervalued longer term) with reported revenues in excess of £30m in it's last report, good positive cash flow and profits. Remind me again about Opti's reported figures and projections for the current year? Next to zero revenues, cash burning and losing money, and yet Opti boasts a higher market cap. Interesting? That leads me on to your question. "Btw Imm and N4p are pharma and we know pharma can be brutal. Whats Opti?" Pharma can be brutal so why did so many Opti holders buy into those two story stocks then? Opti is a low revenue generating, cash guzzling, loss making company that is venturing into pharma. That's what Opti is. Hope that answers your question?
pj 1: FWIW I'm happy for them to hold off on the Skin distribution as I think there will huge appreciation there over the years, as long as there is also appreciation in the OPTI share price.
nimrod22: OPTI share price loves to cycle up and down like a yoyo, its a pity that it never actually takes off despite all the news that it generates. Now lower than what it was two years ago, gofigure.
Optibiotix H. share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180923 08:31:23